Mon, February 14, 2022
Fri, February 11, 2022
Thu, February 10, 2022
Wed, February 9, 2022
Tue, February 8, 2022
Mon, February 7, 2022
Fri, February 4, 2022
Thu, February 3, 2022

Kyle Rose Downgraded (ZBH) to Hold and Decreased Target to $125 on, Feb 8th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-decreased-target-to-125-on-feb-8th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Kyle Rose of Canaccord Genuity, Downgraded "Zimmer Biomet Holdings, Inc." (ZBH) to Hold and Decreased Target from $165 to $125 on, Feb 8th, 2022.

Kyle has made no other calls on ZBH in the last 4 months.



There are 9 other peers that have a rating on ZBH. Out of the 9 peers that are also analyzing ZBH, 6 agree with Kyle's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew O'Brien of "Piper Sandler" Maintained at Hold with Decreased Target to $110 on, Monday, February 7th, 2022
  • Matthew Taylor of "UBS" Downgraded from Strong Buy to Hold and Decreased Target to $130 on, Wednesday, February 2nd, 2022
  • Ryan Zimmerman of "BTIG" Downgraded from Strong Buy to Hold on, Monday, January 10th, 2022
  • Cecilia Furlong of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $145 on, Friday, January 7th, 2022
  • Matt O'Brien of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $135 on, Tuesday, January 4th, 2022
  • David Toung of "Argus Research" Downgraded from Strong Buy to Hold on, Tuesday, November 23rd, 2021


These are the ratings of the 3 analyists that currently disagree with Kyle


  • Larry Biegelsen of "Wells Fargo" Downgraded from Buy to Sell and Decreased Target to $124 on, Wednesday, January 19th, 2022
  • Jason Wittes of "Loop Capital" Initiated at Strong Buy and Held Target at $165 on, Tuesday, December 7th, 2021
  • Anthony Petrone of "Jefferies" Maintained at Strong Buy with Decreased Target to $175 on, Friday, November 5th, 2021

Publication Contributing Sources